 |
 |

Cutaneous Pigmentation Secondary to Amiodarone Therapy
James W. Trimble, MD;
Deborah S. Mendelson, MD;
Bernard F. Fetter, MD;
Peter Ingram, PhD;
John J. Gallagher, MD;
John D. Shelburne, MD, PhD
Arch Dermatol. 1983;119(11):914-918.
Abstract
Amiodarone (Cordarone) is an iodinated cardiac antiarrhythmic drug that causes a slate-gray discoloration of the sun-exposed skin and a yellow-brown stippling of the cornea. Histopathologically, biopsy specimens of aminodarone pigmentation sites disclose yellow-brown refractile granules in the reticular dermis. These granules were characterized by transmission electron microscopy as being concentrically arranged intralysosomal inclusions ("myelinlike" bodies) in dermal endothelial cells and perivascular smooth-muscle cells. Electron probe x-ray analysis of these same inclusions disclosed definite peaks for iodine, evidence for the presence of amiodarone or a metabolite of the drug at these sites. Amiodarone, then, concentrates in lysosomes and causes an accumulation of lipids similar to what has been seen with other cationic amphiphilic compounds, such as the glycosphingolipid stored in Fabry's disease. Amiodarone must be recognized as a cause of a drug-induced lipid storage disease with cutaneous and corneal manifestations.
(Arch Dermatol 1983;119:914-918)
Author Affiliations
From the Divisions of Dermatology (Dr Trimble) and Cardiology (Dr Gallagher), Department of Medicine and the Department of Pathology (Drs Mendelson, Fetter, and Shelburne), Duke University and Veterans Administration Medical Centers, Durham, NC; and the Division of Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, NC (Dr Ingram).
Footnotes
Accepted for publication Dec 24, 1982.
Reprint requests to Department of Pathology, Duke University Medical Center, Box 3712, Durham, NC 27710 (Dr Shelburne).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Cutaneous Manifestations of Adverse Drug Reactions
West and Rumsfield
Journal of Pharmacy Practice 1989;2:251-255.
ABSTRACT
Microprobe Analysis of Chlorpromazine Pigmentation
Benning et al.
Arch Dermatol 1988;124:1541-1544.
ABSTRACT
Dermatologic Problems in the Intensive Care Unit: Part IV
Berman and Silvestri
J Intensive Care Med 1986;1:224-239.
ABSTRACT
Toxic Epidermal Necrolysis and Amiodarone Treatment
Bencini et al.
Arch Dermatol 1985;121:838-838.
ABSTRACT
|